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Abstract 
 
Researcher: Arka Das 
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Congenital Heart Disease 
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Year: 2016 
 
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single 
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for 
decades, but the surgery entails multiple complications and survival rate is less than 50% by 
adulthood. A rapidly testable novel alternative is proposed by creating a bifurcating graft, or 
Injection Jet Shunt (IJS), used to “entrain” the pulmonary flow and thus provide assistance 
while reducing the caval pressure. A benchtop Mock Flow Loop (MFL) is configured to 
validate this hypothesis. The MFL is based on a Lumped-Parameter Model (LPM) of the 
Fontan circulation and is comprised of upper and lower systemic as well as left and right 
pulmonary compartments. Needle valves are used to accurately replicate vascular resistance 
(R) while compliance chambers are used to mimic vascular compliance values (C). The 
Fontan MFL is driven with cardiac pulsatility provided by a Harvard Apparatus medical 
pump. Patient-specific models of the centerpiece of the MFL along with the grafts (IJS) are 
produced via 3D printing. Baseline values are validated against patient-specific waveforms. 
Flow and pressure sensor data at specific points in the MFL are acquired via a National 
Instruments multichannel data acquisition board and processed using LabView. Several IJS 
nozzle diameters are tested to validate the hypothesis and optimize the improvement. 
iv 
 
Table of Contents 
Page 
Thesis Review Committee .................................................................................................. ii 
Acknowledgements ............................................................................................................ iii 
Abstract .............................................................................................................................. iv 
List of Tables ................................................................................................................... viii 
List of Figures .................................................................................................................... ix 
 
Chapter 
I Introduction ..................................................................................................1 
Circulatory Pattern ...........................................................................1 
Cardiac Cycle ...................................................................................2 
Hypo Plastic Left Heart Physiology ................................................4 
Palliative Procedure .........................................................................5 
Roles of Valves and Pulsatile Right Atria .......................................7 
Post Fontan Paradox and Fenestration .............................................9 
II Review of the Relevant Literature .............................................................11 
Physiological Parameters to construct the Loop ............................13 
Blood Volumes ..................................................................13 
Frank Starling Law ............................................................13 
Vascular Compliance.……………………………………14 
Vascular Resistance……………………………………...16 
                                    Hypothesis......................................................................................17 
v 
 
III Methodology ..............................................................................................19 
Pump ..............................................................................................21 
Vascular Compliance .....................................................................23 
Vascular Resistance .......................................................................26 
Injection Jet Shunt..........................................................................27 
IV Experimentation .........................................................................................29 
Components ...................................................................................29 
Test Rig/Table Top ............................................................29 
Harvard Apparatus Pump  ..................................................29 
Compliance Chamber.........................................................30 
Resistors .............................................................................30 
Flow Meters .......................................................................31 
Pressure Sensors.................................................................32 
Data Acquisition System....................................................33 
cDAQ chassis .........................................................33 
Digital module .......................................................34 
Analog module .......................................................35 
Software .............................................................................35 
Calibration of Sensors ........................................................35 
Process ...............................................................................36 
IV Results ........................................................................................................39 
Baseline case ..................................................................................41 
IJS with Open cannula ...................................................................42 
vi 
 
IJS with partially closed cannula ...................................................43 
V Discussion, Conclusions, and Recommendations ......................................44 
Discussion ......................................................................................44 
Conclusions ....................................................................................45 
Future work ....................................................................................45 
References ..........................................................................................................................47 
Appendices 
A Bibliography ................................................................................................# 
B Permission to Conduct Research ...............................................................53 
C Data Collection Device ..............................................................................55 
D Calibration Curves .....................................................................................56 
E Raw Data ....................................................................................................60 
vii 
 
List of Tables 
Page 
Table 
3.1 Anatomically Derived Non-Dimensional Parameter .............................................22 
3.2 Anatomically Derived Frequency and Individual Volumetric Flow rate ..............23 
3.3 Compliances for body surface Area = 0.67m2 .......................................................24 
3.4 Utilized Vascular compliance ................................................................................24 
3.5 Effective radius for desired compliance ................................................................25 
3.6 Pressure drop  .........................................................................................................26 
5.1 Results  ...................................................................................................................39 
 
viii 
 
List of Figures 
Page 
Figure 
1.1 Cardiac cycle event ..................................................................................................3 
1.2 Cardiovascular anatomy for Normal Human Heart and Ailing Heart under  
 HLHS .......................................................................................................................5 
1.3 HLHS and Fontan Circulation .................................................................................6 
2.1 Frank Starling Law. ...............................................................................................14 
3.1 Lumped Parameter Model without IJS. .................................................................20 
3.2 Lumped Parameter Model with IJS .......................................................................20 
3.3 Harvard Apparatus Pump. ......................................................................................21 
3.4 2D CAD model of IJS. ...........................................................................................27 
3.5 Placement of IJS in MFL. ......................................................................................28 
3.6 IJS Prototypes. .......................................................................................................28 
4.1 Compliance chamber in MFL. ...............................................................................30 
4.2 Resistor in MFL. ....................................................................................................31 
4.3 Flow meter installed in MFL .................................................................................32 
4.4 Pressure Sensor installed in MFL ..........................................................................33 
4.5 Labelled diagram of MFL showcasing components of lumped parameter ............37 
4.3 Labelled diagram of MFL Flow showing position of sensors ...............................38 
4.3 Labelled diagram of MFL Flow showing compliance chamber ............................38 
5.1 Figure showing pressure at IVC for baseline and Qp/Qs ratio and pressure at IVC 
for various IJS with fully open Inlet cannula…………………………………….43 
ix 
 
5.2 Figure showing Pressure at IVC for baseline and Qp/Qs ratio and Pressure at IVC 
for various IJS with partially closed Inlet cannula……………………………….44 
5.3 Baseline case with Flow rates ................................................................................44 
5.4 Baseline case with Pressure plots ..........................................................................45 
5.5 Flow rate plot for 2mm IJS with fully open Inlet cannula .....................................45 
5.6 Pressure plot for 2mm IJS with fully open Inlet cannula.......................................46 
5.7 Flow rate plot for 2mm IJS with partially open Inlet cannula ...............................46 
5.8 Pressure plot for 2mm IJS with partially open Inlet cannula .................................47 
 
 
1 
 
Chapter I 
Introduction 
Circulatory pattern  
The heart is located roughly in the center of the chest cavity and protected by a 
membrane called the pericardium. Venous blood from the body enters the right atrium. It 
flows to the right ventricle through the tricuspid valve. The right ventricle contracts and 
the tricuspid valve closes which forces to open the pulmonary valve. Then deoxygenated 
blood flows through pulmonary artery.  This branches immediately, carrying blood to the 
right and left lungs. Carbon dioxide is released from hemoglobin, diffuses out of blood 
cells and capillaries around the alveoli and into the interior of the alveoli, as oxygen 
diffuses from the alveoli, into the capillaries and blood cells and binds to hemoglobin. 
The overall process is called respiration. The capillary beds of the lungs are drained by 
venules that are the tributaries of the pulmonary veins. Two pulmonary veins draining 
from each lung carry oxygenated blood to the left atrium of the heart. Now the 
oxygenated blood flows to the left ventricle through mitral valve. Contraction of the left 
ventricle closes the mitral valve and opens the aortic valve at the entrance to the aorta and 
other two openings lead to the right and left coronary arteries, which supply blood to the 
heart itself. Coronary arteries arise within the heart and pass directly out to its surface and 
extends down across it. These arteries supply blood to the network of capillaries that 
penetrate every portion of the heart. These capillaries drain into two coronary 
veins which returns back to right atrium. The remainder of the blood flow coming out of 
aorta goes to the systemic circulation. The systemic circulation is a branching system of 
arteries that lead to all parts of the body. These arteries lead to capillaries and those in 
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turn drain blood to venules. Veins draining blood of upper portion of the body lead to the 
superior vena cava while veins draining blood of lower portion of the body lead to the 
inferior vena cava. Both superior and inferior vena cava lead to the right atrium.  
 
Cardiac Cycle  
The cardiac cycle refers to the sequence of events from the beginning of one heart 
beat to the initiation of the next beat.  There are two major phases of a cardiac cycle i.e. 
diastole and systole. The heart rate determines the frequency of the cardiac cycle by 
expressing as “heart beats per minute”. Totally there are five major stages in a cycle.  
In the first stage, the atrium contracts and the pressure rises across the atrioventricular 
(AV) valve. The AV valve opens up which makes the blood fill the right ventricle. After 
the atrial contraction the pressure falls down and the valve closes gradually. By the end of 
this stage the right ventricle reaches its maximum volume, known as “End Diastolic 
Volume (EDV)”.  
In the second stage, the right ventricle contracts which increases the ventricular 
pressure to a great extent and the volume remains constant. This stage is also known as 
“Isovolumetric Contraction”.  
The third stage is known as “Rapid ejection,” which occurs when the pressure 
inside the ventricle exceeds the pressure in the pulmonary arteries (10 mmHg) and Aorta 
(80 mmHg) causing the blood to eject out of the ventricles. The rate of ejection is higher 
during the beginning of the stage but gradually slows down as the systole progresses. In 
this stage, ventricular pressure stays a little higher than the pulmonary artery and aortic 
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pressure. Also, a gradual decrease in atrial pressure with the rapid decrease in the 
ventricular volume is also observed.   
In the fourth stage, the ventricular pressure falls below the pulmonary and aortic 
pressure causing a reduced ventricular ejection rate. This flow continues for a short span 
of time due to inertia.   
In the fifth stage, all the AV valves and semilunar valves close. The ventricles 
gets relaxed and the ventricular pressure drops below 120 mmHg. During this stage the 
blood gets pumped to the body through the systemic circulation.   
 
 
Figure 1.1: This figure describes the cardiac cycle events 
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Hypo Plastic Left Heart Physiology 
Hypo-plastic left heart syndrome (HLHS) is a very rare and complex congenital 
heart anomaly where the malformation of the left ventricle and aorta render those 
minimally or non-functional. In this altered physiology, the aortic and mitral valves are 
under developed to cause sufficient amount of blood flow. The blood from the left atrium 
flows to the right ventricle through a defective interatrial septum. This defective 
interatrial septum is also a congenital defect, which is known as “Atrial Septal defect”. 
Therefore the right ventricle is overloaded as it pumps both oxygenated and 
deoxygenated blood to parallel pulmonary and systemic circulations.  
Also the ductus arteriosus usually closes within eleven days after birth 
hence blood flow will be eventually blocked after that period. This may lead to death of 
the baby due to severe lack of oxygenated blood flow in the systemic circulation. HLHS 
can be very fatal, though it may be prevented through surgical interventions. Before the 
surgery takes place, less oxygenated air is passed through the infants suffering from 
HLHS which helps the ductus to remain open and make the blood flow to the systemic 
circulation.  
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Figure 1.2: This figure shows the difference in Human cardiovascular anatomy for a 
normal Human Heart and ailing Heart suffering from HLHS  
 
Palliative Procedure 
A surgery is performed in the following three sequential stages to mitigate the 
flow pattern of HLHS:  
Stage 1: Norwood  
In this stage, atrial septectomy is performed and the hypoplastic aorta is 
reconstructed and connected to the right ventricle in place of the pulmonary root. A 
Blalock Taussig (BT) shunt is implanted between the innominate artery and the 
pulmonary arteries to create a parallel path between the systemic circulation and the 
pulmonary circulation. The Norwood procedure is performed very shortly after birth. 
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Stage 2: Glenn 
In this stage, the superior vena cava (SVC) is disconnected from the right atrium 
and connected directly to the right pulmonary artery and the BT shunt is disconnected. 
The main purpose of this surgery is to send the deoxygenated blood flow from the upper 
systemic circulation to the pulmonary circulation. The Glenn procedure is performed 
between three and six months after the first stage.   
Stage 3: Fontan 
In this stage, the inferior vena cava (IVC) is disconnected from the right atrium 
and connected directly to the pulmonary arteries for a Total Cavopulmonary Connection 
(TCPC), [1]. This results in total passive drainage of the caval blood flow to the 
pulmonary circulation and therefore relieving the single ventricle from pumping blood to 
the pulmonary circulation, see Fig. 2. The atrial septal defect is closed. The Fontan 
procedure is performed around six months to a year after the second stage.   
  
Figure 1.3: Comparison between Hypoplastic Left Heart Syndrome and Fontan 
Circulation  
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Role of Valves and Pulsatile Right Atria 
During the course of time the implementation of valves were investigated 
repeatedly. It was found that stenotic valves were the main reasons for conduit failure. 
Flexibility and plasticity of the valves were also a crucial point of investigation. Many 
research works also revealed that atriopulmonary conduits were not affected by the 
implementation of valves rather affected by the Right Atrium (RA) pressure.  
Now the next point of concern was the inclusion of RA in an univentricular 
circulation because the RA was pulsatile and developing high pressures which often lead 
to cardiac malfunctions like “arrhythmias”, right pulmonary vein obstructions.  The 
original atriopulmonary (AP) connection also made the patient response to the altered 
hemodynamics very unpredictable. This procedure also lead to anomalies like atrial 
flutter and fibrillations.  
Three different procedures of practicing the Fontan surgery are currently 
available. Each is associated with certain amount of complications which are discussed 
below 
 
Intra Atrial Total Cavopulmonary Connection (lateral tunel) 
In 1988, de laval conducted an in-vitro experiments which showed that atrial 
chamber of the conventional atriopulmonary procedure induces turbulence in the flow 
which in turn increases the resistance to the circulation. From those experiments he 
developed an alternative approach to the existing classical AP procedure. In this, the most 
of the RA is excluded hence this procedure is called as Intra-atrial Total Cavopulmonary 
Connection (TCPC). This TCPC is mainly constructed by end to side anastomosis of the 
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Superior Vena Cava (SVC) and Right pulmonary Artery (RPA). This intra-atrial conduit 
was made with composite material and a synthetic graft to strait the Inferior Vena Cava 
(IVC) to the inferior side of RPA through a part of RA wall.   
 
Extra cardiac Total Cavopulmonary Connection 
Around 1990, Marcelleti and colleagues developed a new alternative procedure to 
the existing lateral tunnel method. In this procedure an extra cardiac conduit was used to 
connect IVC to PA through outside of the heart. Hence this procedure is called as “Extra 
cardiac Total Cavopulmonary Connection”. The shunt was made of complex composite 
material and long homograft was used.     
 
Attributes of Three different Fontan Procedures 
In lateral tunnel shows a decreased risk of atrial thrombosis and arrhythmias. 
Also, this conduit procedure showcased less energy losses and turbulence effect. This 
procedure has aortic cross clamping and excessive intra- atrial suture lines. The intra-
atrial baffle has the tendency to generate thrombogenicity. 
The extra cardiac total cavopulmonary process has showcased many advantages. 
This procedure can be performed on patients without arresting their heart and without 
cardiopulmonary bypass. Also, there is no need for extensive atrial suture lines and aortic 
cross-clamping. In this process, the RA is totally avoided and as a result it does not get 
exposed to high venous pressure and high wall stress. This leads to less probability of 
arrhythmias, embolization, atrial flutter and fibrillation.  
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The disadvantage of this procedure is the inability for growth of graft. Also implanted 
homografts are extremely expensive.  
 
Research modalities 
The discovery of TCPC highlighted the importance of investigation of parameters 
like streamline pattern, reduced turbulence, and absence of stagnation in the blood flow. 
Many techniques were reinvestigated to improve the flow pattern and reduce energy 
loses. As it is a single ventricular flow, the energy maintenance was a very crucial factor. 
Other important areas to concern from the surgical point of view were bifurcation angles, 
the degree of offset between anastomoses, material properties and geometry of the shunt.  
 
Post Fontan Paradox and Fenestration 
A "fenestration" is a hole that is usually punctured on the right atrium to relief the 
high pressure developed in the Fontan circuit. Due to this, the pulmonary vascular 
resistance increases and the ventricular function decreases, altering the hemodynamics, 
[2]. In addition, fenestration can also lead to severe congestion of the SVC and/or the 
IVC, arrhythmias, ventricular dysfunction, unusual clinical syndromes of protein-losing 
enteropathy (PLE), and plastic bronchitis. The Fontan procedure often lead to multiple 
complications like chronic illness, severe reduction in quality of life, and chances of 
survival of less than 50% by adulthood [3-10]. In the Fontan circulation, the blood flows 
passively from the systemic circulation return to the pulmonary circulation in the absence 
of the second pumping chamber. This circulatory pattern can fail, even in patients with 
relatively good ventricular function. Pharmacological and other therapies have variable 
10 
 
success [11-14]. The probability of successful outcome with heart transplantation is low 
[15-19]. Some have suggested “assisting” the Fontan circulation using an implanted, 
intravascular, synthetic, externally powered pump [20-23]. Such pumps are under 
laboratory investigation, but problems associated with these pumps (stroke, infection, 
pump failure) still remain. The solutions to these problems are still many years away. 
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Chapter II 
Review of the Relevant Literature 
 
Mock flow loop (MFL) is a bench top model which replicates the human 
circulatory system mechanically for carrying out various in vitro experiments. Generally 
these MFL consist of a pump, a preloaded tank, resistance valves and accumulators. 
These resistance valves and accumulators account for the vascular resistance and vascular 
compliance provided by the circulation. The tank replicates the ventricular bed for the 
pump. The pump can be either pulsatile or continuous depending on the working 
parameters. A detailed literature survey is conducted to determine these important 
parameters and is presented in this section.  
Very first generation MFLs were primarily used for in vitro analysis of artificial 
heart valves where the heart is mimicked by a stepper motor [25]. Also, many setups used 
transparent and flexible ventricles for vulvar flow analysis [26-30]. These MFLs were 
very rudimentary, comprised of very limited elements.       
An MFL as discussed in [31] is comprised of both systemic and pulmonary 
circulations. Compressed air was used as the working fluid for ventricles and huge water 
columns were used to maintain the pressure in the pulmonary arteries. Here, the pressure 
was controlled by the column of water present in the tube, but this tall water column 
induced an undesirable inertia effect in the loop. A flow meter was used to check the 
equality in the amount of flow rate in both systemic and pulmonary circulation.  
In [32] an MFL consisting of only systemic circulation was developed. The whole 
system was submerged into the water filled Perspex box. This Perspex box was 
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connected to the Windkessel model, which can be tuned by the adjustable air volume. 
Each branch of the circulation had a separate resistor. The pulsatile pressure was applied 
by the cam to the whole system.  
A concise summary of the design and analysis of MFL is presented in [33]. It 
describes the features like resistance, compliance, inductance, pulmonary circulations, 
cardiac connections, etc. and their working parameters.  
There is a wide variety of MFLs available. These can vary from two element 
lumped parameter models to five element lumped parameter models. A study conducted 
in [34] compares the accuracy between results produced by a MFL with physiological 
values produced by natural human circulation. It was found that with the addition of each 
element in the loop the generated results were becoming more accurate and resembling 
the physiological values. However, the anomaly was observed upon addition of the fourth 
element into the loop. It did not improve the results by any scale with respect to the three 
element lumped parameter model. The results improved significantly with the inclusion 
of fifth element into the loop. 
An MFL was designed for infants in [34-35]. In this in vitro experiment the 
physiological parameters followed were of infants. The generated results were compared 
with the values for an adult case. The results of this study sets up the baseline reference 
criteria for any infant or neonatal cardiovascular simulation.   
In [36] an MFL containing only a systemic circulation is developed. This MFL 
consisted of a Frank Starling loop to analyze the hemodynamic and ventricular pressure 
volume (PV) behavior for different cardiac assist provided to the loop. The vascular 
resistance was made up of a compliant latex tube in a sealed chamber.  
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A full scale MFL was developed in [37] to simulate the normal and diseased heart 
conditions. The test rig had the ability to produce the Frank Starling effect but was not 
capable of measuring the ventricular volume. This loop had the ability to measure a wide 
extent of flow and pressure values accurately for the ailed and normal heart conditions.  
Though many MFLs were previously constructed to exactly simulate the systemic 
circulation of the human physiology and to test various cardiovascular device, a very 
minimal amount of work has been carried out to replicate the HLHS and to test any 
modified palliative surgery procedures. Also, most of the loops lack a precisely 
controlled variable compliance chamber.    
  
Physiological Parameters to construct the loop  
Blood volumes  
The majority of the volume of blood is stored in the veins of the human body as 
veins are more compliant than arteries. A typical adult can approximately hold 5 liters of 
blood volume in his system.  A study has been conducted in [38] to determine the effect 
of body postures on the blood circulation. It has been found that cardiac output in the 
supine position is around 7.8 L/min, while for the sitting position it is 5.9 L/min. It is also 
mentioned that cardiac output gets increased by 51%.   
A neonatal MFL is created in [39] which had a total volume of 200mL, which 
resembled the blood volume of a neonate weighing 2.7 kg. This loop had simulated only 
main venous flow, central veins and the right atrium.  
In [40] a detailed view of MFL including the parameters like vascular resistance, 
vascular compliance and ventricular volumes were provided.    
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Frank Starling Law  
Frank Starling Law states that human heart has the ability to increase its stroke 
volume with the increase in volume of blood filling the heart. By this law it can also be 
stated that heart works harder to pump more blood hence there is a resistance to 
backflow. This also explains that due to the increased volume of blood the ventricular 
wall stretches during the ventricular preload causing the ventricle to contract more. 
 
 
Figure 2.1: This figure shows the Frank starling Law 
 
Compliance  
By definition compliance means the change of volume of liquid in a chamber with 
respect to the change of pressure in the same chamber.  
Compliance = Change in volume (mL) / Change in Pressure (mmHg) 
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Compliance is inversely proportional to Elastance. The veins are much more compliant 
than arteries, and as a result they can hold a huge amount of blood in them. The 
ventricular compliance determines the end diastolic pressure for a given end diastolic 
volume.  
In [39] the compliance was achieved by trapping the air above the working fluid 
inside each chamber. All four chambers, i.e. systemic arterial, systemic venous, 
pulmonary arterial and pulmonary venous, were variable as the volume of trapped air 
could be changed.  
The same MFL as discussed in [40] was developed for a hemolysis study of the 
Ventricular Assist Device (VADs). This loop utilized a compliance chamber which was 
made of sacs. The sac was submerged into the chamber. The chamber was just big 
enough to fit a sac inside it, hence the compliance was restricted by the size of the 
chamber.  
A new design of compliance chamber was presented in this study [41]. This 
design is based on a spring mass system. A conical seat was made to fit the spring exactly 
in the center position of the piston. The spring constant was calculated by using the 
following equation: 
          𝐾𝐾 = 𝐴𝐴𝑐𝑐2
𝐶𝐶
                                                                          (1) 
Where K is the spring constant, Ac is the Area of the Piston rod and C is the 
desired compliance value.  From the equation it can be seen that variable compliance 
could be achieved by using different diameter springs. 
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A study had been conducted to analyze the effect of arterial compliance during 
intra -aortic balloon counter pulsation. A variable air based compliance chamber was 
used in this MFL setup. The compliance value was calculated by  
                                               𝐶𝐶 = −𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
                                                                            (2) 
The whole process was considered as isothermal, hence   
                                                  𝐶𝐶 = 𝑑𝑑
𝑑𝑑
                                                                              (3) 
A compliance chamber made of flexible rubber walls was designed in [42]. This 
design had a clear plastic which was used to attach to the distal end of the ventricle. The 
flexible rubber wall helped the flow to dampen the pulse pressure. The variable 
compliance was achieved by changing the flexible diaphragm to match the required 
compliance value.  
In this MFL a compliance chamber was developed for simulating the complacity 
of lungs [43]. This chamber was made of a soft and compliant polyurethane bag which 
was trapped in an air tight rigid box. This box was supplied with compressed air to 
change the compliance value by varying the volume of the bag.  
Previously, many compliance chambers were developed based on the principle 
that the air tight tanks were used to trap the air above the working fluid and the volume of 
the entrapped air used to determine the compliance value in [44]. However, for all of 
these designs the MFL have to be shut down each time to change the compliance. A 
modified technique had been found in [Litwak et al] where an air valve is placed at the 
top of the chamber to control the air intake hence the compliance of the circuit.  
To determine the corrected compliance value  
                𝐶𝐶 = 𝑑𝑑𝑑𝑑𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑑𝑑𝑑𝑑𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
= 𝑑𝑑𝑎𝑎𝑓𝑓𝑎𝑎
𝑑𝑑𝑎𝑎𝑓𝑓𝑎𝑎
= 𝑑𝑑𝑡𝑡𝑎𝑎𝑡𝑡𝑡𝑡−𝐴𝐴𝑡𝑡𝑎𝑎𝑡𝑡𝑡𝑡∙ℎ𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑑𝑑𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓−𝜌𝜌∙𝑔𝑔∙ℎ𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
                                                (4) 
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Where C = Desired compliance, Vtank = Volume of the Tank, Vair = Volume of 
air. An extensive in depth study of estimation of arterial compliance had been carried out 
and compared with previously published results in [45]. In this procedure four two-
element lumped parameter model along with time decay and the area, the two-area 
method was implemented. It also accounted for fluid friction and inertia. In this study 
three element LPM with low frequency impedance and integral method was considered. 
It was found that all the methods associated with two-element LPM generated error less 
than 10%. Finally, as a result, it was inferred that for the systemic arterial tree two-
element LPM model worked much accurately with low frequencies whereas three-
element LPM models worked much more accurately with higher frequencies.  
 
Vascular Resistance 
The vascular resistance plays a very crucial role in the whole circulatory system. 
Different body parts exhibits the resistance in a different way. The aorta offers very little 
resistance to the blood flow whereas the systemic circulation provides a high amount of 
resistance to the blood flow due to the presence of small veins and arteries. Hence, the 
pressure drop across the aorta is lesser than the systemic circulation. Human body has the 
ability to change the effective resistance provided by the vasculature to direct the blood 
flow in different directions. The key parameters which govern the resistance are:  
 Hence  
              𝑅𝑅 ∝  𝑛𝑛∙𝐿𝐿
𝑟𝑟4
            (5) 
Radius of the vasculature (r)  
Length of the vasculature (L)  
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Viscosity of the fluid (n) 
Very primarily the resistance was replicated by electronically controlled pinch 
valve in [3] and [46].  
A new design of vascular resistance was found in [16]. This resistance was based 
on plate rotated about pivot to restrict the flow through the tube. The amount of 
restriction depends on the angle of rotation of a plate mounted on pivot. The plate is 
connected with a bellow. When the aortic or pulmonary pressure increased, the bellow 
was forced to contract which pulled the lever arm, and then the valve plate rotated about 
the pivot.  
The resistance was calculated by      
      𝛥𝛥𝛥𝛥 = 𝑅𝑅 ∙ 𝑄𝑄        (6) 
        𝑅𝑅 = 8∙µ∙𝐿𝐿𝑅𝑅∙𝜋𝜋
𝐴𝐴𝑅𝑅
2         (7) 
 
Hypothesis  
A novel, innovative, rapidly testable alternative is proposed to achieve the same 
endpoints as a synthetic pump in the Fontan circulation. Through this procedure the 
reserve mechanical energy of the heart itself is tapped to “assist” the Fontan circulation 
by creating a novel bifurcating graft, henceforth called the Injection Jet Shunt (IJS), see 
Fig 2. A new, technically straightforward surgical operation is proposed in which this 
graft, originating from either the ventricle or aorta, bifurcates with each tapered distal 
limb sutured into the pulmonary arteries (PA) in such a way that flow is directed parallel 
to each PA and the energy and momentum of this flow is efficiently transferred. The 
principle of this process is based on the “injection jet” mechanism in fluid mechanics that 
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has wide industrial applications in well pumps, enhanced oil recovery, and water eductors 
on underwater archeological sites [24], but this concept has never been used to address 
the failing Fontan paradox. The hypothesis is as follows: The inclusion of an IJS of 
suitable geometry into the “failing Fontan” circulation can (1) decrease IVC pressure and 
(2) increase systemic oxygen delivery while limiting the obligatory left-to-right shunt 
through the graft to a clinically acceptable value. The approach challenges the existing 
paradigm that a synthetic pump is required to assist the Fontan circulation. It addresses 
the critical barriers to progress in this field by offering an alternative, effective palliation 
for the failing Fontan while delaying or circumventing the need for heart transplantation 
and implantation of synthetic pumps with their well-known complications. 
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Chapter III 
Methodology 
 
The bench top Mock Flow Loop (MFL) was modeled to resemble the 
cardiovascular system of the target population, i.e. 6 months old babies with an ailing 
heart for the palliative procedure. This was accomplished using a Lumped-Parameter 
Model (LPM) of the Fontan circulation anatomy with four branches, or lumps, 
representing the upper and lower systemic circulations as well as the left and right 
pulmonary circulations, shown in Fig. 3. This is also referred as a “Base line model”. 
Each analogous lump accounts for both the arterial and venous vasculatures found within 
the physiological anatomy. In the figure, a four way junction mimicked the atrio-
pulmonary conduit based Fontan procedure. Each section of the systemic circulation, i.e. 
upper and lower and pulmonary circulation, i.e. right and left, is represented by two 
elements, i.e. Resistance (R) and Compliance (C) lumped parameters. Here the heart is 
represented as a voltage source. In the next figure it is shown that how the IJS is getting 
connected with RPA and LPA and the heart. It is important to note that the MFL is not 
designed as an artificial equivalent of patient anatomy as the development of such a 
construct is infeasible due to the complexities of the cardiovascular system. Instead, the 
MFL represents an observable analogy to human anatomy, producing flow behavior that 
is physiologically relevant and accurate. 
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Figure 3.1: Lumped Parameter model of Atriopulmonary based Fontan Procedure 
 
Figure 3.2: Lumped Parameter model of proposed self powered Fontan Procedure 
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Pump 
 The MFL will be driven by a Harvard Apparatus pulsatile pump, see Fig. 4. The 
MFL will be operated using water instead of blood, therefore, it is important to matching 
non-dimensional parameters to ensure physiologically relevant behavior. The pulsatile 
pump allows for the adjustment of three variables: output phase ratio, frequency or RPM, 
and stroke volume, that is, the volume of water ejected with each pulse. The proper tuning 
of these settings is done by matching two non-dimensional parameters, which describe 
the flow behavior, to those measured in patient physiology; namely, the Womersley 
number, denoted α, and the Reynolds number, denoted Re, defined such that, 
                                                         
2
D fρπα
µ
=                                                             (8) 
                                                            
 vDRe ρ
µ
=
                                                              (9) 
 
 
Figure 3.3: Harvard Apparatus Large animal Pulsatile Pump 
 
It can be seen that the Womersely number and Reynolds number are functions of 
known physiological values. Therefore, these non-dimensional parameters for the target 
population can be determined using average physiological values from medical literature. 
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As the MFL models the upper systemic circulation, lower systemic circulation, left 
pulmonary circulation, and right pulmonary circulation, it is of interest to derive these non-
dimensional parameters in the superior vena cava, inferior vena cava, left pulmonary arteries 
and right pulmonary arteries. These values have been calculated and tabulated below in 
Table 3.1. 
 
Table 3.1. Anatomically Derived Non-Dimensional Parameters 
Vasculature 
Womersely 
Number Reynolds Number 
Superior Vena Cava 6.89 578.76 
Inferior Vena Cava 6.89 1350.44 
Left Pulmonary Artery 5.52 1085.9 
Right Pulmonary 
Artery 5.52 1085.9 
 
Given that the diameter of tubing used within the MFL is known, the pump 
frequency can be calculated from the Womersley number such that, 
                                              
22f
D
µ α
πρ
 =  
                                                         (10) 
Additionally, the Reynolds number dictates flow velocity based upon the geometry 
of the MFL. This flow velocity can be found such that, 
                                                  
 v Re
D
µ
ρ
=
                                                     (11) 
Knowing that the volumetric flow rate is a function of the velocity and flow cross-
section, the flow rate that must be supplied by the pulsatile pump can be calculated such 
that, 
                                                       Q vA=                                                          (12) 
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The frequency and volumetric flow rate for each lump of the MFL has been 
calculated and tabulated below in Table 3.2. 
 
Table 3.2. Anatomically Derived Frequency and Individual Volumetric Flow Rate 
Vasculature Frequency (cycle/min) 
Volumetric Flow Rate 
(LPM) 
Superior Vena Cava 22.4849 0.3464 
Inferior Vena Cava 22.4849 0.8082 
Left Pulmonary Artery 14.4321 0.5773 
Right Pulmonary Artery 14.4321 0.5773 
 
Recall that the superior systemic circulation is parallel to the inferior systemic 
circulation and the left pulmonary circulation is parallel to the right pulmonary circulation. 
Therefore the volumetric flow rate required of the pump is the sum of the upper and lower 
systemic circulations or the sum of the right and left pulmonary circulations. Also, notice 
that the resulting frequency in the systemic circulation (22.4849 cycle/min) is different than 
that in the pulmonary circulation (14.4321 cycle/min), therefore an average between these 
values will be selected to set the frequency (RPM) of the pump. Given that the Womersley 
number governs the frequency of the pump, the stroke volume is then adjusted such that the 
appropriate volumetric flow rate is achieved, as the flow rate is simply the algebraic product 
of frequency and stroke volume.  
The output phase ratio for the pump is set such that the duration of the pump output 
matches the duration of systole in the cardiac cycle. 
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Vascular Compliance 
In modeling the vascular compliance of the infant anatomy, the MFL defined in 
[47] was simplified by bundling appropriate compliances values in order to match the 
flow loop geometry specified in the experiment. This is summarized in Table 3.3.  
Due to the relative similarity between the IJS Fontan Mock Flow Loop used in 
this experiment and the reduced lumped parameter network model utilized in [25], all but 
the lower systemic compliance could be carried over. 
Table 3.3. Compliances for body surface area (BSA) of 0.67 m2 and 1.2 m2 
BSA: 0.67 m2 1.2 m2 
Cub 2.15 ± 0.06 3.12 ± 0.03 
Cliver 2.17 ± 0.07 4.41 ± 0.14 
Clb 1.32 ± 0.013 3.86 ± 0.06 
Crl (0.69+0.88/4) ± 0.03 (1.70 +1.76/4) ± 0.066 
Cll (0.69+0.88/4) ± 0.03 (1.70 + 1.76/4) ± 0.066 
Ctcpc 0 0 
Civc (0.458+0.88/2) ± 0.03 (0.92 + 1.76/2) ± 0.055 
 
In order to calculate the lower systemic compliance, the liver compliance and 
lower body compliance are combined such that,  
                                            
1
lower ivc
lb liver
1 1C C
C C
−
 
= + + 
 
                                      (13) 
Therefore, the resulting compliance values used in this experiment are given 
below in Table 3.4. 
Table 3.4. Vascular Compliance Utilized in Experiment 
Vascular Branch 
 Vascular Compliance 
(mL/mmHg) 
Cupper, Upper Systemic Compliance 3.12 
Clower, Lower Systemic Compliance 3.86 
Cleft, Left Pulmonary Compliance 2.14 
Cright, Right Pulmonary Compliance 2.14 
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With the values for vascular compliance identified, the compliance elements 
could be constructed in the fashion of a vertical flow accumulator. Traditionally, the 
function defining the vascular compliance in relation to volumetric flow rate is given 
such that, 
                                              ( ) ( ) ( ) ( ){ }gdQ t  C t P t P tdt  = −                                    (14) 
Therefore, 
                                                          ( ) ( )
t1P t  Q t  dt
C ∞−
∆ = ∫                                    (15) 
and, 
                                       ( ) ( ) o
V t  V
C t  
P(t)
−
=
∆
                                                      (16) 
In order to achieve the desired compliance value for the vascular compliance 
elements, the above equation can be modified to describe the compliance as a function of 
the compliance element geometry and fluid parameters.  
                                                VC  
P
∆
=
∆
                                                              (17) 
                                                 
2
eπr hC  
ρg h
∆
=
∆
                                                           (18) 
                                                      e
ρgCr  
π
=                                                           (19) 
Where re is the effective radius of the cylindrical compliance chamber. The 
resulting effective radii for the four compliance chambers are shown below in Table 3.5. 
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Table3.5. Required Effective Radius for Desired Compliance 
Vascular Branch 
 Effective Radius 
(in.) 
Cupper, Upper Systemic Compliance 0.3365 
Clower, Lower Systemic Compliance 0.3742 
Cleft, Left Pulmonary Compliance 0.2787 
Cright, Right Pulmonary Compliance 0.2787 
 
The compliance chambers are constructed of Schedule 40 and Schedule 80 PVC 
pipe; therefore nominal pipe sizes are selected to most closely match the values required to 
produce the appropriate effective radius. In the case of the upper and lower compliance 
elements, an annular design approach was taken to accurately achieve the effective radius 
values.  
 
Vascular Resistance   
In the MFL, the vascular resistance serves two purposes: first, to regulate the 
volumetric flow rate through branches of the loop and, second, to produce pressure losses 
across a lump similar to those observed in human cardiovascular physiology. According 
to medical literature, the upper systemic circulation receives approximately 30% of the 
total systemic blood flow while the lower systemic circulation receives approximately 
70% of the total systemic blood flow. In the pulmonary circulation, the left and right 
branches each receive approximately 50% of the pulmonary blood flow. Thus, the 
vascular resistances are initially adjusted, or tuned, to control the ratio of flow within two 
parallel lumps of the flow loop. 
Once the flow ratios had been met, the vascular resistances were varied in order to 
generate the appropriate pressure losses across each branch, while maintaining the 
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appropriate flow ratios. As the upper systemic branch is in parallel with the lower 
systemic branch, the change in pressure should be equivalent across both branches and is 
equal to the pressure loss across the entire systemic circulation. The same applies to the 
left and right pulmonary branches and the total pulmonary pressure loss. The desired 
changes in pressure are tabulated below in Table 3.6.  
 
Table 3.6. Pressure Drop to be observed across Systemic and Pulmonary Circulations 
Vasculature Pressure Drop (mmHg) 
Systemic Circulation 53 
Pulmonary Circulation 10 
 
Injection Jet Shunt Prototyping 
For the IJS, three prototypes were produced with varying internal diameters: 
2mm, 3mm and 4mm. These were designed to introduce an entrainment jet concentric to 
the flow within the pulmonary artery to which the IJS is grafted. It is theorized that the 
entrainment jet will exchange momentum with the flow in the pulmonary arteries, with 
the hope that this will result in a decrease of the localized vascular resistance at the TCPC 
and therefore decrease the pressure at the IVC. It can be seen in the IJS schematic in Fig. 
5 that the diameter increases at the point of entrainment. This is because a small tube is 
built into the IJS to ensure concentricity of the jet flow. Therefore, to isolate the effects of 
the momentum imparted by the jet stream, the diameter of the vasculature was increased 
around the internal tube such that the flow cross sectional area remains constant. The IJS 
prototypes were 3D-printed, as this provided the best method for the precision 
manufacturing necessary for the geometry. After printing, the IJS were sanded and coated 
with a water-proof sealant to prevent any leaking. 
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Figure 3.4: 2D draft of CAD model of IJS 
 
 
Figure 3.5: Figure showing the placement of IJS in TCPC section 
 
30 
 
 
Figure 3.6: Figure showcasing different prototypes of IJS  
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Chapter IV 
Experimentation 
 
Components 
Test Rig/Table Top 
The table top is an integral part of the whole MFL setup as it holds each and every 
component of the loop at its proper location. This table top is a sturdy frame based 
structure and made of pine wood. Many holes have been drilled at various locations on 
this table top for clamping and mounting the sensors, tubing and chambers and also 
allowing the system to have proper spill drainage and wire harnessing. 
Harvard Apparatus Pump 
This is a pulsatile pump which simulates the pumping action of the heart for large 
animals. It contains heart type ball valves which are made of silicone rubber. The flow 
across these ball valves is very smooth. In this pump design, only materials like silicone 
rubber, acrylic plastic, and PTFE come in contact with the fluid as a result there is a 
minimal chance of hemolysis. It has a mechanically actuated piston which moves back 
and forth in a transparent cylinder head. In this mechanism, the piston travels to the 
farthest end of the cylinder irrespective of the selected stroke volume. This insures that 
the fluid is completely emptied from the cylinder at each stroke. The RPM decal 
determines the frequency of the stroke rate of the piston for a set stroke value and the 
Output to Input phase ratio determine the amount of systole ratio should be present in a 
whole cardiac cycle produced by the pump for a particular Stroke and RPM setting. 
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Compliance chamber: 
  The compliance chambers are made of schedule 40 and schedule 80 PVC pipe. A 
compliance chamber is placed in each of the four compartments of the loop, i.e. upper 
and lower systemic circulation and right and left pulmonary circulation, to mimic the 
compliance offered by that section. 
 
Figure 4.1: Figure showing a compliance chamber installed in the MFL  
 
Resistors 
Needle valves have been used as a resistor to incorporate resistance in each 
section of MFL. These are made up of Stainless steel with ½” inch NPT Female thread 
size. It has a very accurate flow rate range which lies between 0-22.5 (GPM) and the 
pressure range from 0-5000 PSI with cracking pressure of 1-2.5 (PSI). 
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Figure 4.2: The figure showing the resistor installed in the MFL 
 
Flow Meters 
A flow meter is placed in every compartment of the flow loop to measure the flow 
rate provided by that section. These flow meters work on turbine based principle and 
mainly applicable for low flow rate applications. The turbine technology provides a high 
accuracy for flow rate applications. Due to the smaller diameter, the inertia of the turbine 
is very low hence this sensor reacts quickly to on/off dispensing applications. This sensor 
can measure the flow rate from 0.1 to 2.5 LPM. 
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Figure 4.3: The figure showing a flow meter installed in the MFL 
 
 
Pressure Sensors 
 These are very precise and robust analog pressure sensors. In total there are four 
pressure sensors installed in the whole MFL. One is installed in the Aortic flow line, i.e. 
the line connecting the pump to the bifurcation of the systemic circulation, and another 
two are placed in upper and lower part of the systemic circulation. The last one is placed 
in the venous flow line, i.e. the line returning from the pulmonary circuit to the reservoir. 
These sensors can read any pressure of the range 0-15 PSIG and generates 0-100 mV 
35 
 
respectively.
 
Figure 4.4: The figure showing a pressure sensor installed in the MFL: 
Tubing 
To mimic the whole vasculature of the body a ½ inch inner diameter hose is used 
throughout he MFL. This hose is made of clear braided PVC reinforced materials. 
 
Figure 4.4: The figure showing a pressure sensor installed in the MFL:  
 
Data Acquisition System (DAQ) 
To acquire all the signals from these sensors (flow meters and Pressure sensor) a 
Data Acquisition module of national Instrument is used. This is a modular chassis based 
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data acquisition system with eight slots to input different modules of Analog and Digital 
senor readers. There are three major components of this system: 
cDAQ chassis 
The cDAQ-9174 is a 4-slot CompactDAQ USB chassis designed for small, 
portable, mixed-measurement test systems. Combine the cDAQ-9174 with up to four NI 
C Series I/O modules for a custom analog input, analog output, digital I/O, and 
counter/timer measurement system. Out of these four slots only two are used by a digital 
module NI 9361and another one is an analog module, i.e. NI 9205. One Compact DAQ 
systems combine sensor measurements with voltage, current, and digital signals to create 
custom, mixed-measurement systems with a single, simple USB cable back to the PC, 
laptop, or netbook. The cDAQ-9174 has four 32-bit general-purpose counter/timers built 
in. These counters can be accessed through an installed, hardware-timed digital NI C 
Series module such as the NI 9401 or NI 9402 for applications that involve quadrature 
encoders, PWM, event counting, pulse train generation, and period or frequency 
measurement. 
 
Digital module 
This digital module- NI 9361 is being used to log data sent by each of the 
flowmeters. This module is an 8-channel differential or single-ended counter input 
module for Compact DAQ. Each channel is configured to read a single pulse train or 
combine them to read up to four incremental encoders. Sensors can be directly connected 
with open-collector or push-pull outputs. It has eight flexible, 32-bit counters where each 
counter is capable of standard counter measurements such as edge counting, pulse width, 
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period, and frequency measurements. In addition, the counters can perform encoder 
position and velocity measurements. The NI 9361 counters provide enhanced frequency 
and duty-cycle (PWM) measurements. The counters support a dynamic averaging mode, 
so you can obtain frequency measurements that are optimized for accuracy and latency 
from 0 Hz up to high rates. For duty-cycle measurements, the counters can correctly 
measure over the full range from 0 percent to 100 percent. As the flow meters are turbine 
based, a pulse train is generated when it sees the flow. Therefore the frequency 
measurement output was selected and then by configuring the sample size, and buffer 
size parameter in this module the frequency of the pulse train is obtained. 
 
Analog Module  
The National Instruments 9205 is a C Series module, for use with NI 
CompactDAQ and CompactRIO chassis. The NI 9205 features 32 single-ended or 16 
differential analog inputs, 16-bit resolution, and a maximum sampling rate of 250 kS/s. 
Each channel has programmable input ranges of ±200mV,±1,±5,and10V.There are two 
connector options for the NI 9205; a 36-position spring terminal connector for direct 
connectivity or a 37-position D-Sub connector. As a result, this module is used to acquire 
the voltage signal sent by each of the pressure sensors. 
 
Software 
A code is written in Labview software to plot the raw data, i.e. frequency and 
voltage values acquired from the flow meters and pressure sensor respectively on real 
time basis. Then these raw data values were logged in an excel spread sheet format. After 
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that, a Matlab script was developed to do the post processing on these logged data to 
obtain the flow rate values and pressure values. 
 
Calibration of Flowmeters 
At first, the pump is set to produce a specific output. The flowmeter which has to 
be calibrated is placed in line to the line connecting the pump and graduated reservoir. 
Now, the time taken by water to fill a specific volume level in the graduated reservoir is 
obtained by using a chronometer. Hence the flow rate of the system is calculated from 
this “Time duration” and “Volume”. For the same volume, the frequency values 
generated by these flowmeter are logged in an excel spread sheet in the workstation using 
Labview code. Now, the flowrate and frequency values are logged into another excel 
spread sheet and plotted against each other. A linear curve fit technique was used to find 
the calibration equation for that particular flowmeter for a good R2 value. The same 
experiment was conducted with four different volume levels and for three different pump 
settings. 
 
Calibration of Pressure Sensor 
Calibration equation of the pressure sensor was obtained from the data sheet 
provided by the company. 
 
Process 
The pulsatile pump is set such that an output of 1.2 liter per minute (lpm) is 
produced; this requires pump settings of 40 RPM and 30 cubic centimeters (cc) per 
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stroke. The output phase ratio is set to 35 percent in order to match the ratio of systole to 
the entire heart cycle. The resistors are tuned in such a way that the 30% of the total 
systemic flow diversion towards the upper circulation and 70% of the total systemic flow 
diversion towards the lower circulation of the body. The ratio of pulmonary flow to 
systemic flow is one. Also, the return flow is equally split between both the right and left 
pulmonary circuit. The flow coming out of the pulmonary circuit directly goes back to 
the tank through the venous return line. 
The flow rates and pressure values are logged using a National Instruments Data 
Acquisition System. This constitutes the baseline data set, as the flow loop geometry 
represents the typical Fontan circulation anatomy. 
Then the IJS is added to the flow loop, which generated a parallel circuit that 
bypasses the systemic circulation. Additionally, a gate valve is attached at the distal end 
of the graft from the TCPC section, which simulates the total resistance provided by the 
graft. Again, the flow loop is run and data is recorded with the IJS and the gate valve 
fully open. Then, gradually, the gate valve is closed until the effective resistance provided 
by the graft is replicated. Pictures detailing the MFL setup are presented in Figures 6 
through 8. In essence, this will output varying pressures and flowrates with the different 
shunts. 
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Figure 4.5: A labelled figure of the complete MFL showing the elements of lumped 
parameter 
 
Figure 4.5: A labelled figure showing the position of sensors and the flow directions 
in the MFL 
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Figure 4.5: A labelled figure showing the position of compliance chambers and 
resistors in the MFL. 
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Chapter V 
Results 
 
The resulting flow characteristics for the baseline case as well as those produced 
by the partially closed and fully open IJS inlet cannula are tabulated in this section. The 
baseline configuration replicates the physiological flow and pressure values for the 
failing Fontan circulation case. The cardiac output is 1.24lpm while maintaining the 30% 
of the total systemic flow diversion towards the upper circulation and 70% of the total 
systemic flow diversion towards the lower circulation of the body. The ratio of pulmonary 
flow to systemic flow is one. Also, the return flow is equally split between both the right 
and left pulmonary circuit. The obtained aortic and caval pressures are analogous to the 
values of a failing Fontan circulation. Then by introducing different diameter IJS into the 
mock flow loop with the gate valve fully open, that is, in “Fully open Inlet cannula” 
configuration, the ratio of pulmonary flow (Qp) to systemic flow (Qs) increases to the 
range of 2.09-3.89 achieving an IVC pressure reduction of up to 4.94mmHg with respect 
to the Baseline case. Then in the “Partially closed Inlet cannula” configuration, the ratio 
Qp/Qs is reduced to the range 1.6-1.78 while the IVC pressure is reduced by as much as 
5.86mmHg with respect to the Baseline case. The summary of the results is presented 
below in Table 5.1. 
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Table 5.1. Results of Experiment 
 
 
Fully Open IJS Inlet Cannula Partially Closed IJS Inlet Cannula 
 Baseline 2mm IJS 3mm IJS 4mm IJS 2mm IJS 3mm IJS 4mm IJS 
Cardiac Ejection (lpm) 1.24 1.099 1.125 1.169 1.017 1.0361 1.0362 
QU/QS (%) 30 29.12 34.75 37.47 33 29.35 31.34 
QL/QS (%) 70 70.88 65.25 62.53 67 70.64 68.66 
QRP/QP (%) 49.53 47.23 46.66 45.19 45 45.9 41.42 
QLP/QP (%) 50.47 52.77 53.34 54.81 55 54.1 58.58 
QP/QS 1 2.09 3.05 3.89 1.62 1.66 1.78 
PAO (mmHg) 75.7 32.22 27.34 24.51 39.22 37 36.66 
PIVC (mmHg) 20.48 15.54 16.57 17.53 15.12 15.1 14.62 
PSVC (mmHg) 20.2 15.12 16.02 17.07 14.7 14.67 14.19 
PATR (mmHg) 3.257 1.13 1.248 2.084 0.889 0.801 0.79 
 
 
 
 
Figure 5.1: Figure showing the Pressure values at IVC for baseline model and 
Pressure at IVC and Qp/Qs ratio for different diameter Jet shunt when the inlet 
cannula is fully open 
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Figure 5.2: Figure showing the Pressure values at IVC for baseline model and 
Pressure at IVC and Qp/Qs ratio for different diameter Jet shunt when the inlet 
cannula is partially closed 
 
Baseline case 
Here flow rates and pressure plots for the baseline model has been showcased. 
  
Figure 5.3: Flow rates of baseline model (Top to Bottom) – Upper Circulation, 
Lower Circulation, Right Pulmonary Circulation and Left Pulmonary Circulation   
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Figure 5.4: Pressure Plot of baseline model (Top to Bottom) – Upper Circulation, 
Lower Circulation, Pulmonary Circulation and Aortic Circulation 
 
With Fully Open IJS Inlet Cannula 
Case 1: With 2mm IJS  
In this case, the 2mm IJS was tested in the MFL while the inlet cannula was kept 
in fully open position. 
 
Figure 5.5: Flow rate plot for 2mm IJS with fully open Inlet cannula (Top to 
Bottom) – Upper Circulation, Lower Circulation, Right Pulmonary Circulation and 
Left Pulmonary Circulation 
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Figure 5.6: Pressure Plot for 2mm IJS with fully open Inlet cannula (Top to Bottom) 
– Upper Circulation, Lower Circulation, Pulmonary Circulation and Aortic 
Circulation 
 
With Partially Closed IJS Inlet Cannula 
Case 1: With 2mm IJS  
In this case, the 2mm IJS was tested in the MFL while the inlet cannula was kept 
in partially closed position 
  
Figure 5.7: Flow rate Plot for 2mm IJS partially open Inlet cannula Upper 
Circulation, Lower Circulation, Right Pulmonary Circulation and Left Pulmonary 
Circulation 
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Figure 5.8: Pressure Plot for 2mm IJS partially open Inlet cannula (Top to Bottom) 
– Upper Circulation, Lower Circulation, Pulmonary Circulation and Aortic 
Circulation.  
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Chapter VI 
Discussion, Conclusions, and Future Work 
 
In this section we will elaborate on the results in detail along with the conclusion 
of this thesis. Future work for this project will also be discussed, and this will entail the 
future recommendation and modification to this experiment. Future work will also 
discuss how this experiment may be upgraded to the next level.  
 
Discussion 
 It is observed that the increased IJS diameter results in a decreased resistance in the 
IJS graft, as the area reduction is less severe; hence yielding higher IJS flow rate and 
therefore higher Qp/Qs ratio. For the 2mm “fully open IJS inlet cannula” configuration, the 
IVC pressure reduction was 4.94mmHg yielding a Qp/Qs ratio of 2.09 while larger IJS 
(3mm and 4mm) produced less IVC pressure reductions at larger Qp/Qs ratios (up to 3.05). 
These values of IVC pressure reduction are promising, but they come at the expense of 
excessive IJS flow (and therefore excessive Qp/Qs ratios) which will in turn reduce the 
resulting systemic flow and, therefore, deprive the body of oxygenated blood.  
 
Partially closure of Inlet cannula 
 In order to restrict the IJS flow and therefore limit the Qp/Qs ratio, the gate valve of 
the IJS valve is partially closed to achieve the maximum physiologically allowed Qp/Qs 
ratio of approximately 1.7. Partially closing the gate valve essentially simulates a steeper 
degree of implantation of the IJS graft in the Aorta or simply a smaller diameter graft. For 
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the 2mm “partially closed IJS inlet cannula” configuration, the IVC pressure reduction was 
5.36mmHg yielding a Qp/Qs ratio of 1.62 while larger IJS (3mm and 4mm) gradually 
produced higher IVC pressure reductions at Qp/Qs ratios that did not exceed 1.8. This 
results clearly show the trend of how the IJS entrainment effect reduces the localized 
vascular resistance at the TCPC and lowers the resulting caval pressures 
 
Conclusions 
A novel alternative to the Fontan circulation that includes a bifurcating graft, or 
Injection Jet Shunt (IJS), is experimentally tested. The IJS is used to “entrain” the 
pulmonary flow and thus provide assistance while reducing the caval pressure. A benchtop 
Mock Flow Loop (MFL) is configured to validate this hypothesis. The MFL is based on a 
Lumped-Parameter Model (LPM) of the Fontan circulation and is comprised of upper and 
lower systemic, as well as, left and right pulmonary compartments. Several IJS nozzle 
diameters are tested to validate the hypothesis and optimize the improvement. The inclusion 
of the IJS in the Fontan circulation is observed to indeed produce an entrainment effect 
that results in a reduction of the localized vascular resistance at the TCPC and therefore 
yielding the desired reduction of the caval pressure. However, the inclusion of the IJS in 
the MFL resulted in a reduction in cardiac ejection so the entire caval pressure reduction 
cannot be fully attributed to the entrainment effect. Future work will focus on the 
physiological response due to reduced cardiac ejection and systemic flow, such as 
increased cardiac function and decreased vasculature resistance, to simulate homeostatic 
reaction during the post-operative period.    
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Future Work 
In future work, a method to account for change in pulmonary vascular resistance 
with the change in pulmonary flow rate will be incorporated in the MFL. A baroreceptor 
reflex setting will be added to the loop. The designs of IJS will be revised to make the 
insertion angle as shallow as possible. Also, instead of turbine based flow meters, 
magnetic flow meters will be installed in the loop, which will make the flow rate data 
very accurate. The LabView code will be modified in such a way that a separate post 
processing script will not be necessary.  
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Appendix C 
 
Data Collection Device 
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Appendix D 
 
Calibration Curves  
 
D2.1 Calibration curve of Pressure sensor in Upper Circulation  
 
   
 
D2.2 Calibration curve of  Pressure sensor in Lower Circulation  
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D2.3 Calibration curve of Pressure sensor in Pulmonary Circulation  
 
 
 
D2.4 Calibration curve of  Pressure sensor in Aortic Circulation  
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D2.5 Calibration curve of Flow meter 1 
 
 
 
D2.6 Calibration curve of Flow meter 2 
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D2.7 Calibration curve of Flow meter 3 
 
 
 
D2.8 Calibration curve of  Flow meter 4  
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Appendix E 
 
Raw Data 
 
E2.1 Flow rate plots of 3mm IJS with fully open Inlet Cannula 
 
E2.2 Pressure plots of 3mm IJS with fully open Inlet Cannula 
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E2.3  Flow rate plots of 4mm IJS with fully open Inlet Cannula  
 
E2.4 Pressure plots of 4mm IJS with fully open Inlet Cannula 
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E2.5 Flow rate plots of 3mm IJS with partially open Inlet Cannula   
 E2.6 Pressure plots of 3mm IJS with partially open Inlet Cannula   
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E2.7 Flow rate plots of 4mm IJS with partially open Inlet Cannula   
 E2.8 Pressure plots of 4mm IJS with partially open Inlet Cannula   
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